Biopsy-proven autoimmune myocarditis in HIV-associated dilated cardiomyopathy

被引：10
作者：
Frustaci A. [1 ]
Petrosillo N. [1 ]
Francone M. [2 ]
Verardo R. [1 ]
Ippolito G. [1 ]
Chimenti C. [1 ]
机构：
[1] National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Biocardiology Laboratory, Rome
[2] La Sapienza University, Radiological Sciences Department, Rome
来源：
BMC Infectious Diseases | / 14卷 / 1期
关键词：
Biopsy (Heart); Heart failure; HIV (Human immunodeficiency virus); Myocarditis; Recovery of function;
D O I：
10.1186/s12879-014-0729-3
中图分类号：
学科分类号：
摘要：
Background: Dilated cardiomyopathy occurring in HIV-infected patients raises both diagnostic and therapeutic challenging problems. Indeed myocardial involvement in HIV infection has been variously attributed to several causes, including viral, toxic, nutritional and autoimmune, but no specific treatment capable to substantially improve patients' prognosis has been recognized so far. Case Presentation: Hereby we describe the case of an autoimmune myocarditis manifesting with heart failure in a3 9-year-old man with HIV infection. Conclusion: Presence of auto-reactive myocarditis should be considered in patients with HIV-associated dilated cardiomyopathy. Its recognition by endomyocardial biopsy followed by steroid administration may result in a complete resolution of cardiac disease. © Frustaci et al.
引用
收藏
相关论文
共 13 条
  • [1] Hajjar L.A., Calderaro D., Yu P.C., Guiliano I., Oliviera L.E.M., Barbaro G., Caramelli B., Cardiovascular manifestations in patients infected with the human immunodeficiency virus, Arq Bras Cardiol, 85, pp. 363-377, (2005)
  • [2] Sani M.U., Myocardial disease in human immunodeficiency virus (HIV) infection: a review, Wien Klin Wochenschr, 120, pp. 77-87, (2008)
  • [3] Calabarese L.H., Proffitt M.R., Yen-Lieberman B., Hobbs R.E., Ratliff N.B., Congestive cardiomyopathy and illness related to the acquired immunodeficiency syndrome (AIDS) associated with isolation of retrovirus from myocardium, Ann Intern Med, 107, pp. 691-692, (1989)
  • [4] Fantoni M., Autore C., Borgo C., Drugs and cardiotoxicity in HIV and AIDS, Ann NY Acad Sci, 946, pp. 179-199, (2001)
  • [5] Hoffman M., Lipshultz S.E., Miller T.L., Malnutrition and cardiac abnormalities in the HIV-infected patients., Nutritional aspects of HIV infection., pp. 33-39, (1999)
  • [6] Herskowitz A., Willoughby S.B., Vlahov D., Baughman K.L., Ansari A.A., Dilated heart muscle disease associated with HIV infection, Eur Heart J, 16, pp. 50-55, (1995)
  • [7] Frustaci A., Chimenti C., Calabrese F., Pieroni M., Thiene G., Maseri A., Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders, Circulation, 107, pp. 857-863, (2003)
  • [8] Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, Eur Heart J, 34, 33, pp. 2636-2648, (2013)
  • [9] Kuhl U., Lassner D., Schlippenbach J., Poller W., Schultheiss H.P., Interferon-Beta improves survival in enterovirus-associated cardiomyopathy, J Am Coll Cardiol, 60, pp. 1295-1296, (2012)
  • [10] Drucker N.A., Colan S.D., Lewis A.B., Beiser A.S., Wessel D.L., Takahashi M., Baker A.L., Perez-Atayde A.R., Newburger J.W., Gamma-globulin treatment of acute myocarditis in the pediatric population, Circulation, 89, pp. 252-257, (1994)
12